---
title: "Zepbound (tirzepatide) in chronic weight management: Pharmacology questions"
description: "Pharmacology questions on Zepbound (tirzepatide) in chronic weight management, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Mechanism. Questions: How does Zepbound work (mechanism of action)? Does Zepbound cause more fat loss than lean (muscle) mass loss? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/pharmacology"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Zepbound (tirzepatide) in chronic weight management: Pharmacology questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Zepbound](https://uspl.lilly.com/zepbound/zepbound.html#pi)

Pharmacology questions that apply to every indication of Zepbound are on [Zepbound (tirzepatide), all indications: Pharmacology](https://www.evicenter.com/medical-information/zepbound/pharmacology).

## Mechanism

<a id="zepbound-mechanism"></a>

### How does Zepbound work (mechanism of action)?

> “Tirzepatide is a GIP receptor and GLP-1 receptor agonist. It contains a C20 fatty diacid that enables albumin binding and prolongs the half-life. Tirzepatide selectively binds to and activates both the GIP and GLP-1 receptors, the targets for native GIP and GLP-1.
>
> GLP-1 is a physiological regulator of appetite and caloric intake. Nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake.
>
> Both GIP receptors and GLP-1 receptors are found in areas of the brain involved in appetite regulation. Animal studies show that tirzepatide distributes to and activates neurons in brain regions involved in regulation of appetite and food intake.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=Tirzepatide%20is%20a%20GIP%20receptor,of%20appetite%20and%20food%20intake.)

> “Tirzepatide decreases calorie intake. The effects are likely mediated by affecting appetite.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=Tirzepatide%20decreases%20calorie%20intake.%20The%20effects%20are%20likely%20mediated%20by%20affecting%20appetite.)

> “Tirzepatide delays gastric emptying. The delay is largest after the first dose and this effect diminishes over time.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=Tirzepatide%20delays%20gastric%20emptying.%20The,this%20effect%20diminishes%20over%20time.)

<a id="zepbound-fat-vs-muscle"></a>

### Does Zepbound cause more fat loss than lean (muscle) mass loss?

> “Tirzepatide lowers body weight with greater fat mass loss than lean mass loss.”

Source: [ZEPBOUND: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/zepbound/zepbound.html#pi:~:text=Tirzepatide%20lowers%20body%20weight%20with,loss%20than%20lean%20mass%20loss.)

## Related pages
- [Medical information: Zepbound (tirzepatide): Chronic weight management](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management)
- [Indication](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/safety)
- [Dosing and administration](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/zepbound--chronic-weight-management/access-and-coverage)
